drugset / Trial / NCT02564328

Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke

NCT02564328 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.Stem cell transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous bone marrow mesenchymal stem cells in patients with chronic stroke.

Timeline

Start
2014-11
Primary completion
2016-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator autologous bone marrow mesenchymal stem cells Cell therapy — Intravenous

Indications